$CEOS provides the following corporate update to s
Post# of 42189
(Total Views: 153)
Posted On: 11/23/2021 12:08:24 PM
$CEOS provides the following corporate update to shareholders.
The company has successfully navigated unprecedented difficulty with regard to the effects of COVID19 on international supply chains by securing 900 kilograms of premium quality mushrooms, complete with certificates of analysis from approved producers. Upon final approval of PsyKey's product formulations, the six different functional mushroom strains will be used in the development of our retail product offerings. The procurement of these ingredients has been overseen by a highly qualified mycologist, aligning with our commitment at the forefront of the company's retail vision to offer consumers the highest quality ingredients and products.
Over the past two quarters, PsyKey Inc. has looked to further bolster its management and advisory personnel and has engaged in discussions with key international distribution partners, and continues ongoing discussions with previously announced partnership opportunities.
Beginning next week management will be meeting with its current manufacturing and distribution partners to prepare for the next steps in bringing our product offerings to fruition. In addition to finalizing our initial retail strategy, management will also be visiting potential laboratory and production facilities to further its plan for future growth and research potential. We are excited to be entering the next phase of our business strategy and feel that we have created a solid foundation to continue to build upon in the months and years to come.
We would like to thank our valued shareholders for their patience and continued support. We are committed to updating the marketplace when key developments and milestones are achieved.
For further information:
(OTC PINK:CEOS)
www.psykeyworld.com
E-mail: info@psykeyworld.com
Follow us on Twitter: https://twitter.com/PsyKeyworld
https://www.barchart.com/story/news/2737835/p...ate-update
The company has successfully navigated unprecedented difficulty with regard to the effects of COVID19 on international supply chains by securing 900 kilograms of premium quality mushrooms, complete with certificates of analysis from approved producers. Upon final approval of PsyKey's product formulations, the six different functional mushroom strains will be used in the development of our retail product offerings. The procurement of these ingredients has been overseen by a highly qualified mycologist, aligning with our commitment at the forefront of the company's retail vision to offer consumers the highest quality ingredients and products.
Over the past two quarters, PsyKey Inc. has looked to further bolster its management and advisory personnel and has engaged in discussions with key international distribution partners, and continues ongoing discussions with previously announced partnership opportunities.
Beginning next week management will be meeting with its current manufacturing and distribution partners to prepare for the next steps in bringing our product offerings to fruition. In addition to finalizing our initial retail strategy, management will also be visiting potential laboratory and production facilities to further its plan for future growth and research potential. We are excited to be entering the next phase of our business strategy and feel that we have created a solid foundation to continue to build upon in the months and years to come.
We would like to thank our valued shareholders for their patience and continued support. We are committed to updating the marketplace when key developments and milestones are achieved.
For further information:
(OTC PINK:CEOS)
www.psykeyworld.com
E-mail: info@psykeyworld.com
Follow us on Twitter: https://twitter.com/PsyKeyworld
https://www.barchart.com/story/news/2737835/p...ate-update
(0)
(0)Scroll down for more posts ▼